AzTrials
AzTrials

Postoperative CareNCT03777150

Is There a Benefit of Postoperative ICU Management After Elective Surgery in Critical Ill Patients?

A study testing Postoperative care in Intensive care unit (ICU) and Postoperative care in standard ward in people with Postoperative Care and Intensive Care, run by Saint Savvas Anticancer Hospital at 1 site in Greece.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Postoperative care of high risk patients in the Intensive Care Unit (ICU) has for long been considered to be the gold standard of care in terms of reducing perioperative mortality.New evidence from a 7-day cohort study involving 27 countries comes to question this practice. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Postoperative Care, Intensive Care
What is being tested?
Postoperative care in Intensive care unit (ICU) and Postoperative care in standard ward
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteGreece
Study dates
10 Oct 2018to Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All patients that will be scheduled for an elective operation and are considered to be in a high perioperative risk

Who cannot join

  • Patients that are operated on an emergency basis

Trial locations and contacts

1 site in 1 country.

Georgia Micha, MD, PhD contact

6974828254 ext. 0030

mgeo3@yahoo.gr

Vasiliki Chantziara, MD, PHD contact

6937173376 ext. 0030

vchantziara@yahoo.gr

Greece1 site, 1 recruiting
  • Saint Savvas Anticancer Hospital of Athens

    Athens

    Georgia Micha, MD, MSc, PhD, +306974828254

    Recruiting

Other trials in Greece

About this study

Official title: Is There a Benefit of Postoperative ICU Management After Elective Surgery in Terms of Patient's Outcome, Length of Hospital Stay, Complications and Cost?

Postoperative care of high risk patients in the Intensive Care Unit (ICU) has for long been considered to be the gold standard of care in terms of reducing perioperative mortality.New evidence from a 7-day cohort study involving 27 countries comes to question this practice. The primary objective of our study is to detect any benefit of postoperative ICU care after elective surgery in terms of patient's outcome, length of hospital stay, complications and cost.

Read the detailed description

A prospective analysis of high perioperative risk patients that are about to be subjected into an elective operation will be included into the study. They will be allocated into two groups. Group ICU patients are those that are admitted into the ICU for postoperative care and those that are admitted into a standard ward consist Group Ward. Demographic data, the length of hospital stay, the outcome, the need of mechanical ventilation, the complications and the total cost will be recorded.

Being tested
Postoperative care in Intensive care unit (ICU), Postoperative care in standard ward
Keywords
Intensive care, postoperative care, elective surgery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Postoperative care in Intensive care unit (ICU)Other

    Postoperative care in Intensive care unit (ICU)

  • Postoperative care in standard wardOther

    Postoperative care in standard ward

Study groups in NCT03777150
Study groupRoleWhat they receive
Group ICUExperimentalGroup ICU:patients are admitted directly into the ICU for postoperative care
Receives: Other: Postoperative care in Intensive care unit (ICU)
Group WardExperimentalGroup Ward:patients are admitted directly into the standard ward for postoperative care
Receives: Other: Postoperative care in standard ward

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total length of hospital stay

    The total length of patient's hospital stay will be recorded

    Measured: From date of hospital admission until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 6 months

Secondary outcomes (6)
  1. Preoperative length of hospital stay

    The preoperative length of patient's hospital stay will be recorded

    Measured: From date of hospital admission until the date of operation or date of death from any cause, whichever came first, assessed up to 6 months

  2. Postoperative length of hospital stay

    The postoperative length of patient's hospital stay will be recorded

    Measured: From date of surgical operation until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 6 months

  3. Postoperative complications

    All postoperative complications will be recorded

    Measured: From date of surgical operation until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 6 months

  4. Patient's outcome at 28 days postoperatively

    28 day postoperative mortality will be recorded

    Measured: From the first postoperative day until 28 days postoperatively

  5. Total cost of hospital care

    The total cost of hospital care will be recorded for every patient

    Measured: From date of hospital admission until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 6 months

  6. Postoperative cost of hospital care

    The postoperative cost of hospital care will be recorded for every patient

    Measured: From date of surgical operation until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2018
  2. Study start10 Oct 2018
  3. Primary completionDec 2020 (estimated)
  4. Study completionJun 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Group I: admitted into the ICU for postoperative care Group II: admitted into a standard ward for postoperative care
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03777150
Sponsor's protocol ID
ICU postoperative care
Status last verified
Dec 2018
First submitted
10 Dec 2018
Last updated
17 Dec 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Postoperative care in Intensive care unit (ICU) and Postoperative care in standard ward in people with Postoperative Care and Intensive Care, run by Saint Savvas Anticancer Hospital at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Georgia Micha, MD, PhD (6974828254 ext. 0030, mgeo3@yahoo.gr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total length of hospital stay (time frame: From date of hospital admission until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Dec 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in